CA19-9：意大利的经验。

CA19-9: the Italian experience.

作者信息

Gullo L

机构信息

Institute of Medicine and Gastroenterology, University of Bologna, St. Orsola Hospital, Italy.

出版信息

Pancreas. 1994 Nov;9(6):717-9.

Abstract

This article reviews studies of the diagnostic value of CA19-9 determination in pancreatic cancer in Italy. Almost all of these studies show that CA19-9 determination has a good sensitivity in the diagnosis of advanced pancreatic cancer and that its diagnostic accuracy is superior to that of the other serum tumor markers currently available. Although data from patients with early pancreatic cancer are limited, they indicate that the diagnostic value of CA19-9 in these patients is low.

摘要

本文综述了意大利关于CA19-9检测在胰腺癌诊断价值方面的研究。几乎所有这些研究都表明，CA19-9检测在晚期胰腺癌诊断中具有良好的敏感性，其诊断准确性优于目前可用的其他血清肿瘤标志物。尽管早期胰腺癌患者的数据有限，但这些数据表明CA19-9在这些患者中的诊断价值较低。

相似文献

1

CA19-9: the Italian experience.

Pancreas. 1994 Nov;9(6):717-9.

2

Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.

Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):464-8.

3

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007.

4

CEACAM1, a novel serum biomarker for pancreatic cancer.

Pancreas. 2007 May;34(4):436-43. doi: 10.1097/MPA.0b013e3180333ae3.

5

TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions.

Anticancer Res. 1999 Jan-Feb;19(1B):849-51.

6

Serum CA19-9 determination in the management of pancreatic cancer.

Hepatogastroenterology. 1996 May-Jun;43(9):710-3.

7

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].

Ai Zheng. 2003 Mar;22(3):295-7.

8

[CA19-9 has no value as a tumor marker in obstructive jaundice].

Schweiz Med Wochenschr. 1999 Jan 23;129(3):77-9.

9

A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

Am J Gastroenterol. 1999 Jul;94(7):1941-6. doi: 10.1111/j.1572-0241.1999.01234.x.

10

[Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].

Gastroenterol Hepatol. 1999 Aug-Sep;22(7):335-41.

引用本文的文献

1

Diagnosis of pancreatic cancer using serum proteomic profiling.

Neoplasia. 2004 Sep-Oct;6(5):674-86. doi: 10.1593/neo.04262.

2

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.

Dig Dis Sci. 2004 Aug;49(7-8):1149-55. doi: 10.1023/b:ddas.0000037803.32013.aa.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。